Fundraising Fox

Avicenna Biosciences

Durham, US · Founded 2020 · Delaware corporation · 3 known investors

biocentury.com ↗

BioCentury provides business intelligence, market analysis, and networking services for biotech and pharmaceutical industry leaders. The platform offers curated databases of companies, funding, partnerships, and competitive insights to help executives identify opportunities and track market trends.

BiotechData & InfrastructureEnterprise Softwarein /biocentury@BioCentury

Founders & leadership

PB
Pieter BurgerExecutive Officer, Director
TK
Thomas KaiserExecutive Officer, Director
CM
Christopher MeldrumExecutive Officer, Director
JH
John HamerDirector
DL
Dennis LangerDirector

Investors · 3

DCVC (Data Collective)Palo Alto · $5M – $25M
Sound BioventuresMalmö
DCVC BioreportedPalo Alto

Reported raises · per SEC filings

Form D private placements
▶$70.7KraisedOct 2025 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pieter BurgerExecutive Officer, Director
  • John HamerDirector
  • Dennis LangerDirector
  • Thomas KaiserExecutive Officer, Director
  • Christopher MeldrumExecutive Officer, Director
Offering amount
$70.7K
Amount sold
$70.7K
First sale
Feb 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedJul 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pieter BurgerExecutive Officer, Director
  • Christopher MeldrumExecutive Officer, Director
  • Thomas KaiserExecutive Officer, Director
  • Dennis LangerDirector
  • John HamerDirector
Offering amount
$6M
Amount sold
$6M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedFeb 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John HamerDirector
  • Christopher MeldrumExecutive Officer, Director
  • Thomas KaiserExecutive Officer, Director
  • Pieter BurgerExecutive Officer, Director
  • Dennis LangerDirector
Offering amount
$10M
Amount sold
$6M
First sale
Nov 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedDec 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dennis LangerDirector
  • John HamerDirector
  • Pieter BurgerDirector
  • Thomas KaiserExecutive Officer, Director
  • Christopher MeldrumExecutive Officer, Director
Offering amount
$6M
Amount sold
$3M
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedSep 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pieter BurgerDirector
  • Christopher MeldrumExecutive Officer, Director
  • Thomas KaiserDirector
Offering amount
$2.5M
Amount sold
$2.5M
First sale
Aug 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.